[实时或动态非侵入性肝纤维化检测用于评估临床预后和预测慢性肝病]
1Beijing Friendship Hospital, Capital Medical University, Clinical Epidemiology & EBM Unit, Beijing 100050, China.
概括
非侵入性测试 (NIT) 的动态监测显示出预测肝病结果的前景,但需要更多的研究来确认其优于静态评估. 这种方法可以改善临床决策.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学诊断 医学诊断 医学诊断
- 数据科学数据科学数据科学
背景情况:
- 肝纤维化是慢性肝病预后的一个关键指标.
- 非侵入性测试 (NITs) 提供预测价值,但动态对静态评估的优势仍在争论中.
研究的目的:
- 系统地审查关于NIT和肝脏不良事件纵向变化的证据.
- 在预测模型中评估动态NIT监控的附加值.
主要方法:
- 系统的文献审查.
- 分析来自非侵入性试验的纵向数据.
- 探索时间序列机器学习用于动态建模.
主要成果:
- 对于预测结果,NIT的动态监测似乎优于单个评估.
- 目前的证据有限,在研究中存在显著的异质性.
- 转向高级建模,如时间序列机器学习,是必要的.
结论:
- 动态NIT监测具有个性化肝病管理的潜力.
- 进一步的研究对于克服疾病分层,建模,数据质量和预测准确性的局限性至关重要.
- 目标是将NIT转化为临床决策支持的动态工具.
更多相关视频
10:10Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
Published on: July 20, 2022
4.5K
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
426
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
526
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
526
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209